By adding Wegovy to their Medicare formularies, plans may experience higher patient satisfaction ratings in their CAHPS (Consumer Assessment of Healthcare Providers and Systems) surveys in Rating of Drug Plans (D05 measure) and Getting Needed Prescription Drug (D06 measure)
In STEP-1 and STEP-5, injection site reactions were reported in a small percentage of participants, but they were mostly mild and rarely led to treatment withdrawal
While we respect every healthcare providers clinical expertise and their right to prescribe treatment based on their own medical judgment, we ask that healthcare professionals prescribe our medicines consistent with their FDA-approved indications. Still, disproportionate access and increasingly common off-label use dont mean that semaglutide medications are being misused, health care providers say
GLP-1 based therapies:differential effects on fasting and postprandial glucose
That translates to 200 mg to 1,200 mg of tirzepatide per day, depending on the target dose
in 2024
